Nurix Therapeutics NRIX reported its Q4 earnings results on Thursday, January 27, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Nurix Therapeutics missed estimated earnings by 23.19%, reporting an EPS of $-0.85 versus an estimate of $-0.69, which surprised analysts.
Revenue was up $707.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03, which was followed by a 1.16% increase in the share price the next day.
Here's a look at Nurix Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.62 | -0.54 | -0.46 | -0.54 |
| EPS Actual | -0.65 | -0.60 | -0.63 | -0.51 |
| Revenue Estimate | 8.57M | 8.23M | 7.94M | 3.94M |
| Revenue Actual | 10.25M | 7.09M | 5.01M | 6.69M |
Listen to the earnings announcement yourself by clicking here.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
